Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -19.87% is 25% below its 5-year average of -15.88%, around the middle of its 5-year range (-28.06%–-1.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.32% above its 12-month average of -20.77%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -19.87%.
RETURN ON INVESTED CAPITAL (ROIC)
-19.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-20.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-20.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-15.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.32%
CURRENT VS 3Y AVG
+3.84%
CURRENT VS 5Y AVG
-25.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 766 covered companies
CURRENT VS SECTOR MEDIAN
+42.29%
vs the sector median at left
GH Research PLC
Market Cap
$1.48B
Return on Invested Capital (ROIC)
-19.87%
TTM Avg
-20.77%
3Y Avg
-20.67%
5Y Avg
-15.88%
Market Cap
$1.47B
Return on Invested Capital (ROIC)
-35.66%
TTM Avg
-26.24%
3Y Avg
-27.95%
5Y Avg
-27.95%
Market Cap
$1.49B
Return on Invested Capital (ROIC)
11.91%
TTM Avg
9.57%
3Y Avg
7.02%
5Y Avg
7.35%
Market Cap
$1.46B
Return on Invested Capital (ROIC)
16.83%
TTM Avg
6.43%
3Y Avg
6.32%
5Y Avg
5.53%
Market Cap
$1.50B
Return on Invested Capital (ROIC)
20.41%
TTM Avg
-2.25%
3Y Avg
-13.09%
5Y Avg
-29.56%
Market Cap
$1.45B
Return on Invested Capital (ROIC)
0.59%
TTM Avg
0.35%
3Y Avg
-0.10%
5Y Avg
-0.25%
Market Cap
$1.44B
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.44B
Return on Invested Capital (ROIC)
-53.48%
TTM Avg
-44.88%
3Y Avg
-46.83%
5Y Avg
-39.47%
Market Cap
$1.44B
Return on Invested Capital (ROIC)
-28.63%
TTM Avg
-6.26%
3Y Avg
-69.26%
5Y Avg
-69.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GH Research PLC (GHRS) | $1.48B | -19.87% | -20.77% | -20.67% | -15.88% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | -35.66% | -26.24% | -27.95% | -27.95% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 11.91% | 9.57% | 7.02% | 7.35% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 16.83% | 6.43% | 6.32% | 5.53% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 20.41% | -2.25% | -13.09% | -29.56% |
| Certara, Inc. (CERT)vs › | $1.45B | 0.59% | 0.35% | -0.10% | -0.25% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.44B | N/A | N/A | N/A | N/A |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -53.48% | -44.88% | -46.83% | -39.47% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.44B | -28.63% | -6.26% | -69.26% | -69.26% |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 33.76% | 23.76% | -16.29% | 5.45% |
ROIC
-19.9%
ROE
-17.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -19.87% |
| 2026-03-31 | -25.31% |
| 2025-12-31 | -21.68% |
| 2025-09-30 | -19.52% |
| 2025-06-30 | -17.47% |
| 2025-03-31 | -16.59% |
| 2024-12-31 | -28.06% |
| 2024-09-30 | -25.56% |
| 2024-06-30 | -22.91% |
| 2024-03-31 | -20.13% |
| 2023-12-31 | -18.77% |
| 2023-09-30 | -17.33% |
| 2023-06-30 | -15.46% |
| 2023-03-31 | -13.59% |
| 2022-12-31 | -12.23% |
| 2022-09-30 | -10.91% |
| 2022-06-30 | -9.89% |
| 2022-03-31 | -8.15% |
| 2021-12-31 | -5.45% |
| 2021-09-30 | -3.10% |
| 2021-06-30 | -1.46% |
| 2021-03-31 | -36.32% |
| 2020-12-31 | -7.87% |
